Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311808564> ?p ?o ?g. }
- W4311808564 endingPage "3161" @default.
- W4311808564 startingPage "3161" @default.
- W4311808564 abstract "Levosimendan, a calcium sensitizer, has an organ protective profile through the inhibition of inflammatory mediators and cytokines in critical conditions, such as heart failure, ischemia-reperfusion injury, and sepsis. The survival effect of levosimendan for acute liver failure has not been examined yet. Male Sprague-Dawley rats were examined in the D-galactosamine hydrochloride and lipopolysaccharide (GalN/LPS) model. Levosimendan was injected intraperitoneally before GalN/LPS treatment. Survival was monitored for 7 days. For biochemical analyses, liver and blood samples were collected from the rats at 1 and 8 h after GaIN/LPS treatment. The pretreatment of levosimendan at 4 mg/kg significantly increased survival in GalN/LPS rats. In the liver specimen, levosimendan significantly inhibited the activation of nuclear factor-κB (NF-κB) at 1 h, and significantly decreased the mRNA expression of inflammatory mediators, including inducible nitric oxide synthase and tumor necrosis factor-α (TNF-α), at 8 h. In serum, levosimendan decreased the levels of nitrite, a metabolite of nitric oxide, and TNF-α protein, as well as aspartate aminotransferase and alanine aminotransferase. These results indicated that Levosimendan ameliorated liver dysfunction and survival in acute liver failure model rats through the suppression of NF-κB activation." @default.
- W4311808564 created "2022-12-28" @default.
- W4311808564 creator A5002647339 @default.
- W4311808564 creator A5007274064 @default.
- W4311808564 creator A5019450003 @default.
- W4311808564 creator A5043799958 @default.
- W4311808564 creator A5051416234 @default.
- W4311808564 creator A5053874442 @default.
- W4311808564 creator A5076949349 @default.
- W4311808564 creator A5077940502 @default.
- W4311808564 date "2022-12-07" @default.
- W4311808564 modified "2023-10-18" @default.
- W4311808564 title "Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model" @default.
- W4311808564 cites W1506254633 @default.
- W4311808564 cites W1847621205 @default.
- W4311808564 cites W1982502858 @default.
- W4311808564 cites W1990802251 @default.
- W4311808564 cites W1992536611 @default.
- W4311808564 cites W2004463597 @default.
- W4311808564 cites W2004465286 @default.
- W4311808564 cites W2005717288 @default.
- W4311808564 cites W2007790231 @default.
- W4311808564 cites W2021656111 @default.
- W4311808564 cites W2029058958 @default.
- W4311808564 cites W2030470859 @default.
- W4311808564 cites W2040624527 @default.
- W4311808564 cites W2049069390 @default.
- W4311808564 cites W2064927551 @default.
- W4311808564 cites W2066184732 @default.
- W4311808564 cites W2099540110 @default.
- W4311808564 cites W2128635872 @default.
- W4311808564 cites W2134812217 @default.
- W4311808564 cites W2143642767 @default.
- W4311808564 cites W2319741033 @default.
- W4311808564 cites W2401926099 @default.
- W4311808564 cites W2558296997 @default.
- W4311808564 cites W2745159723 @default.
- W4311808564 cites W2770094938 @default.
- W4311808564 cites W2939817410 @default.
- W4311808564 cites W2974055171 @default.
- W4311808564 cites W3087827298 @default.
- W4311808564 cites W3173715707 @default.
- W4311808564 cites W3202964273 @default.
- W4311808564 cites W3205099924 @default.
- W4311808564 cites W4224254906 @default.
- W4311808564 cites W4293247451 @default.
- W4311808564 cites W4294216491 @default.
- W4311808564 cites W4296816736 @default.
- W4311808564 doi "https://doi.org/10.3390/biomedicines10123161" @default.
- W4311808564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36551917" @default.
- W4311808564 hasPublicationYear "2022" @default.
- W4311808564 type Work @default.
- W4311808564 citedByCount "0" @default.
- W4311808564 crossrefType "journal-article" @default.
- W4311808564 hasAuthorship W4311808564A5002647339 @default.
- W4311808564 hasAuthorship W4311808564A5007274064 @default.
- W4311808564 hasAuthorship W4311808564A5019450003 @default.
- W4311808564 hasAuthorship W4311808564A5043799958 @default.
- W4311808564 hasAuthorship W4311808564A5051416234 @default.
- W4311808564 hasAuthorship W4311808564A5053874442 @default.
- W4311808564 hasAuthorship W4311808564A5076949349 @default.
- W4311808564 hasAuthorship W4311808564A5077940502 @default.
- W4311808564 hasBestOaLocation W43118085641 @default.
- W4311808564 hasConcept C126322002 @default.
- W4311808564 hasConcept C134018914 @default.
- W4311808564 hasConcept C178790620 @default.
- W4311808564 hasConcept C17991360 @default.
- W4311808564 hasConcept C185592680 @default.
- W4311808564 hasConcept C2776179834 @default.
- W4311808564 hasConcept C2776384668 @default.
- W4311808564 hasConcept C2776637226 @default.
- W4311808564 hasConcept C2777335384 @default.
- W4311808564 hasConcept C2777622882 @default.
- W4311808564 hasConcept C2778125326 @default.
- W4311808564 hasConcept C2778198053 @default.
- W4311808564 hasConcept C2778384902 @default.
- W4311808564 hasConcept C2778754761 @default.
- W4311808564 hasConcept C2781467277 @default.
- W4311808564 hasConcept C519581460 @default.
- W4311808564 hasConcept C55493867 @default.
- W4311808564 hasConcept C71924100 @default.
- W4311808564 hasConcept C98274493 @default.
- W4311808564 hasConceptScore W4311808564C126322002 @default.
- W4311808564 hasConceptScore W4311808564C134018914 @default.
- W4311808564 hasConceptScore W4311808564C178790620 @default.
- W4311808564 hasConceptScore W4311808564C17991360 @default.
- W4311808564 hasConceptScore W4311808564C185592680 @default.
- W4311808564 hasConceptScore W4311808564C2776179834 @default.
- W4311808564 hasConceptScore W4311808564C2776384668 @default.
- W4311808564 hasConceptScore W4311808564C2776637226 @default.
- W4311808564 hasConceptScore W4311808564C2777335384 @default.
- W4311808564 hasConceptScore W4311808564C2777622882 @default.
- W4311808564 hasConceptScore W4311808564C2778125326 @default.
- W4311808564 hasConceptScore W4311808564C2778198053 @default.
- W4311808564 hasConceptScore W4311808564C2778384902 @default.
- W4311808564 hasConceptScore W4311808564C2778754761 @default.
- W4311808564 hasConceptScore W4311808564C2781467277 @default.
- W4311808564 hasConceptScore W4311808564C519581460 @default.